Metropolis Healt
Diagnostics & Research · METROPOLIS
Mid CapHealthcareMature Stable
Ameera Shah
Executive Chairperson · Visionary
Company DNA
Founder-Centric
About
Metropolis Healt is a Mid Cap company in the Healthcare sector, listed on NSE as METROPOLIS. With a market cap of ₹9K Cr and revenue of ₹1K Cr, it is currently in the Mature Stable phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Ameera Shah is the public face and architect of the company’s expansion; the culture remains closely aligned to her vision for diagnostic excellence. Its strategic mandate: In a crowded diagnostic market, the company must focus on supply chain optimization and network density to maintain margins against aggressive local competitors.
FAQ
What kind of company is Metropolis Healt?
Metropolis Healt is a Mid Cap Healthcare company (METROPOLIS) in the Mature Stable phase with a market cap of ₹9K Cr. It is classified as Founder-Centric in culture.
What is Metropolis Healt's culture and work environment like?
Metropolis Healt has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Learning Ground. Customer relationship style: Mass-Consumer. Ameera Shah is the public face and architect of the company’s expansion; the culture remains closely aligned to her vision for diagnostic excellence.
Who leads Metropolis Healt?
Metropolis Healt is led by Ameera Shah (Executive Chairperson), a Visionary leader with 24 years of experience.
What are Metropolis Healt's financials?
Metropolis Healt reported revenue of ₹1K Cr in FY25 with a 5-year revenue CAGR of 2.7%. Operating margin: 15.5%. Market cap: ₹9K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerMass-Consumer
EmployeeLearning Ground
BrandTrusted
LifecycleMature Stable
Ameera Shah is the public face and architect of the company’s expansion; the culture remains closely aligned to her vision for diagnostic excellence.
Mandate
In a crowded diagnostic market, the company must focus on supply chain optimization and network density to maintain margins against aggressive local competitors.
In a crowded diagnostic market, the company must focus on supply chain optimization and network density to maintain margins against aggressive local competitors.
Financials
Revenue FY25₹1K Cr
PAT FY25₹145 Cr
Rev CAGR 5Y2.7%
OPM15.5%
NPM10.9%
ROE10.9%
ROCE13.1%
P/E55.9
Fwd P/E36.9
P/B6.5
D/E13.9
Mkt Cap₹9K Cr
Promoter49.9%
Institutional44%
Similar Culture
Could You Lead Metropolis Healt?
Take the Genome Benchmark →